晚期慢性肾病患者-话题@MedSci

#晚期慢性肾病患者#

8篇内容 | 1117人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2076737, encodeId=720f20e673799, content=<a href='/topic/show?id=e9955983549' target=_blank style='color:#2F92EE;'>#晚期慢性肾病患者#</a>, objectTitle=JAMA 子刊：老年晚期慢性肾病患者高剂量氟喹诺酮治疗与严重不良事件的关系, objectType=article, longId=735354, objectId=8ed3e3535450, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ed3e3535450, replyNumber=0, likeNumber=76, createdTime=2023-04-04, rootId=0, userName=1249842em09(暂无昵称), userId=1ac22500003, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ed3e3535450, moduleTitle=JAMA 子刊：老年晚期慢性肾病患者高剂量氟喹诺酮治疗与严重不良事件的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ed3e3535450)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2076734, encodeId=3e7a20e67342e, content=<a href='/topic/show?id=e9955983549' target=_blank style='color:#2F92EE;'>#晚期慢性肾病患者#</a>, objectTitle=BMJ：早早开始透析可降低晚期慢性肾病患者的死亡率和心血管事件风险, objectType=article, longId=221424, objectId=08382214240c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08382214240c, replyNumber=0, likeNumber=84, createdTime=2022-09-18, rootId=0, userName=1249842em09(暂无昵称), userId=1ac22500003, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08382214240c, moduleTitle=BMJ：早早开始透析可降低晚期慢性肾病患者的死亡率和心血管事件风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08382214240c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2076736, encodeId=c77720e673690, content=<a href='/topic/show?id=e9955983549' target=_blank style='color:#2F92EE;'>#晚期慢性肾病患者#</a>, objectTitle=JAMA子刊：GLP-1受体激动剂与DPP-4抑制剂的使用与2型糖尿病和晚期慢性肾病患者死亡率的关系, objectType=article, longId=300317, objectId=525d30031e63, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=525d30031e63, replyNumber=0, likeNumber=182, createdTime=2022-07-17, rootId=0, userName=1249842em09(暂无昵称), userId=1ac22500003, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=525d30031e63, moduleTitle=JAMA子刊：GLP-1受体激动剂与DPP-4抑制剂的使用与2型糖尿病和晚期慢性肾病患者死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=525d30031e63)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2076735, encodeId=6e6d20e673509, content=<a href='/topic/show?id=e9955983549' target=_blank style='color:#2F92EE;'>#晚期慢性肾病患者#</a>, objectTitle=NEJM：氯噻酮治疗晚期慢性肾病患者高血压的疗效如何？, objectType=article, longId=293133, objectId=c2c3293133dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2c3293133dd, replyNumber=0, likeNumber=104, createdTime=2022-01-14, rootId=0, userName=1249842em09(暂无昵称), userId=1ac22500003, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2c3293133dd, moduleTitle=NEJM：氯噻酮治疗晚期慢性肾病患者高血压的疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2c3293133dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2076733, encodeId=b9d820e6733c5, content=<a href='/topic/show?id=e9955983549' target=_blank style='color:#2F92EE;'>#晚期慢性肾病患者#</a>, objectTitle=NEJM：采用氯噻酮控制晚期慢性肾病患者失控的高血压, objectType=article, longId=220112, objectId=1c22220112e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c22220112e1, replyNumber=0, likeNumber=90, createdTime=2022-01-14, rootId=0, userName=1249842em09(暂无昵称), userId=1ac22500003, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c22220112e1, moduleTitle=NEJM：采用氯噻酮控制晚期慢性肾病患者失控的高血压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c22220112e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2076732, encodeId=cb7320e673267, content=<a href='/topic/show?id=e9955983549' target=_blank style='color:#2F92EE;'>#晚期慢性肾病患者#</a>, objectTitle=Circulation：阿哌沙班 PK 华法林用于房颤合并晚期慢性肾病患者抗凝！, objectType=article, longId=193485, objectId=d12f19348556, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d12f19348556, replyNumber=0, likeNumber=87, createdTime=2021-04-08, rootId=0, userName=1249842em09(暂无昵称), userId=1ac22500003, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d12f19348556, moduleTitle=Circulation：阿哌沙班 PK 华法林用于房颤合并晚期慢性肾病患者抗凝！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d12f19348556)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2076731, encodeId=a5a120e673139, content=<a href='/topic/show?id=e9955983549' target=_blank style='color:#2F92EE;'>#晚期慢性肾病患者#</a>, objectTitle=JAMA Intern Med:多学科讨论：强化降压能降低晚期慢性肾病患者死亡风险？, objectType=article, longId=117840, objectId=f86311e84014, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f86311e84014, replyNumber=0, likeNumber=82, createdTime=2018-05-16, rootId=0, userName=1249842em09(暂无昵称), userId=1ac22500003, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f86311e84014, moduleTitle=JAMA Intern Med:多学科讨论：强化降压能降低晚期慢性肾病患者死亡风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f86311e84014)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2076730, encodeId=9b4220e6730bd, content=<a href='/topic/show?id=e9955983549' target=_blank style='color:#2F92EE;'>#晚期慢性肾病患者#</a>, objectTitle=Lancet：对于晚期慢性肾病患者，不提倡使用二甲双胍, objectType=article, longId=52305, objectId=2eac5230598, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2eac5230598, replyNumber=0, likeNumber=86, createdTime=2015-12-27, rootId=0, userName=1249842em09(暂无昵称), userId=1ac22500003, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2eac5230598, moduleTitle=Lancet：对于晚期慢性肾病患者，不提倡使用二甲双胍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2eac5230598)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

晚期慢性肾病患者

2020-05-29

1249842em09(暂无昵称) (审核中...)

前往app查看评论内容

#晚期慢性肾病患者#

JAMA 子刊：老年晚期慢性肾病患者高剂量氟喹诺酮治疗与严重不良事件的关系

2023-04-04

1249842em09(暂无昵称) (审核中...)

前往app查看评论内容

#晚期慢性肾病患者#

BMJ：早早开始透析可降低晚期慢性肾病患者的死亡率和心血管事件风险

2022-09-18

1249842em09(暂无昵称) (审核中...)

前往app查看评论内容

#晚期慢性肾病患者#

JAMA子刊：GLP-1受体激动剂与DPP-4抑制剂的使用与2型糖尿病和晚期慢性肾病患者死亡率的关系

2022-07-17

1249842em09(暂无昵称) (审核中...)

前往app查看评论内容

#晚期慢性肾病患者#

NEJM：氯噻酮治疗晚期慢性肾病患者高血压的疗效如何？

2022-01-14

1249842em09(暂无昵称) (审核中...)

前往app查看评论内容

#晚期慢性肾病患者#

NEJM：采用氯噻酮控制晚期慢性肾病患者失控的高血压

2022-01-14

1249842em09(暂无昵称) (审核中...)

前往app查看评论内容

#晚期慢性肾病患者#

Circulation：阿哌沙班 PK 华法林用于房颤合并晚期慢性肾病患者抗凝！

2021-04-08

1249842em09(暂无昵称) (审核中...)

前往app查看评论内容

#晚期慢性肾病患者#

JAMA Intern Med:多学科讨论：强化降压能降低晚期慢性肾病患者死亡风险？

2018-05-16

1249842em09(暂无昵称) (审核中...)

前往app查看评论内容

#晚期慢性肾病患者#

Lancet：对于晚期慢性肾病患者，不提倡使用二甲双胍

2015-12-27

科室
- - 订阅+
  - 更多科室
工具
服务